Physician profile
Ashley Goad
NPI 1154803179
$1,220.23
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $325 · 2022: $577 · 2023: $169 · 2024: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $250.73 | 2022-2024 | Farxiga |
| Sobi, INC | $120.75 | 2023 | |
| Alexion Pharmaceuticals, INC. | $118.48 | 2021 | |
| Stemline Therapeutics INC. | $115.61 | 2022 | |
| Abbvie INC. | $109.22 | 2022 | |
| Genzyme Corporation | $101.60 | 2022 | |
| Eisai INC. | $89.68 | 2021 | |
| Braeburn INC. | $88.10 | 2024 | Brixadi |
| Biohaven Pharmaceuticals, INC. | $83.79 | 2021 | |
| Urgo Medical North America, LLC | $64.53 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Medline Industries LP | $27.78 | 2023 | |
| Novo Nordisk INC | $17.24 | 2021 | |
| Paratek Pharmaceuticals, INC. | $17.04 | 2022 | |
| Kci USA, INC. | $15.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Goad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.